Single Dose of Doxycycline for the Prevention of Tick-borne Relapsing Fever.
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
23 10 2020
23 10 2020
Historique:
received:
28
08
2019
accepted:
15
01
2020
pubmed:
20
1
2020
medline:
28
4
2021
entrez:
20
1
2020
Statut:
ppublish
Résumé
The current postexposure prophylaxis regimen for tick-borne relapsing fever (TBRF) consists of 5 days' doxycycline. In this observational study of 77 spelunkers at high risk for TBRF, a single dose of 100 mg doxycycline taken up to 72 hours after exposure to ticks was 100% effective in preventing the disease.
Identifiants
pubmed: 31955197
pii: 5709628
doi: 10.1093/cid/ciaa034
doi:
Substances chimiques
Doxycycline
N12000U13O
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1768-1771Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.